F. Stephen Hodi

Researcher Next ID · RN-001262

Researcher · Medicine

Cambridge, United States

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Cancer Immunotherapy and Biomarkers

CAR-T cell therapy research

Immunotherapy and Immune Responses

Melanoma and MAPK Pathways

Cutaneous Melanoma Detection and Management

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Nature · 2014 · https://doi.org/10.1038/nature14011
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200690
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa1003466

No projects listed.